(Average reading time – 1 minute)
The Anne Rowling Clinic is currently the main recruitment site in Scotland for AD-SMART, a new UK trial launched today, aiming to accelerate the testing of potential treatments for Alzheimer’s disease. Professor Suvankar Pal is the local Principal Investigator, leading the Clinic’s involvement in the study.
AD-SMART uses an innovative trial design to test multiple medicines simultaneously, rather than evaluating each treatment in a separate trial. This approach could more than halve the time needed to test potential Alzheimer’s treatments, helping researchers identify promising therapies more efficiently.
The Clinic’s involvement highlights its commitment to advancing clinical research and improving outcomes for people affected by neurodegenerative conditions.
Discover more about the UK-wide trial and its potential to transform Alzheimer’s treatment research
Read the full announcement from the UK Dementia Research Institute: New UK trial could more than halve time it takes to test Alzheimer’s treatments.
Further information
AD-SMART is led by the University College London Innovative Clinical Trials Unit.
Find out more on the AD-SMART research project page on ARRNC website: AD-SMART project page
Funder(s)
UK Dementia Research Institute, Alzheimer's Research UK, and the National Institute for Health and Care Research (NIHR).
Header image produced with Canva